Arlene Morris, Chief Executive Officer of Affymax, Inc., Rings the NASDAQ Closing Bell
November 19, 2008 - Affymax, Inc. [AFFY]
About this Marketsite Event:
Arlene Morris, Chief Executive Officer of Affymax, Inc., presides over the Closing Bell.
About Affymax, Inc.:
Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions.
Affymax's product candidate, Hematide (tm), is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure.
For additional information, please visit www.affymax.com.
Press Inquiries Only:
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at
jolene.libretto@nasdaq.com. Kindly credit © 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.
Other Photography Inquiries:
For all other photography inquiries, please contact NASDAQ’s photographer, Rob Tannenbaum at
rob.tannenbaum@nasdaq.com.
© 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.
